LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,089
تعداد مقالات9,995
تعداد مشاهده مقاله26,532,957
تعداد دریافت فایل اصل مقاله7,303,165
Ebrahimoghli, Reza, Janati, Ali, Sadeghi-Bazargani, Homayoun, Hamishehkar, Hadi, Khalili-Azimi, Atefeh. (1400). Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study. سامانه مدیریت نشریات علمی, 47(1), 53-62. doi: 10.30476/ijms.2020.87284.1742
Reza Ebrahimoghli; Ali Janati; Homayoun Sadeghi-Bazargani; Hadi Hamishehkar; Atefeh Khalili-Azimi. "Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study". سامانه مدیریت نشریات علمی, 47, 1, 1400, 53-62. doi: 10.30476/ijms.2020.87284.1742
Ebrahimoghli, Reza, Janati, Ali, Sadeghi-Bazargani, Homayoun, Hamishehkar, Hadi, Khalili-Azimi, Atefeh. (1400). 'Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study', سامانه مدیریت نشریات علمی, 47(1), pp. 53-62. doi: 10.30476/ijms.2020.87284.1742
Ebrahimoghli, Reza, Janati, Ali, Sadeghi-Bazargani, Homayoun, Hamishehkar, Hadi, Khalili-Azimi, Atefeh. Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study. سامانه مدیریت نشریات علمی, 1400; 47(1): 53-62. doi: 10.30476/ijms.2020.87284.1742

Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study

Iranian Journal of Medical Sciences
مقاله 8، دوره 47، شماره 1، فروردین 2022، صفحه 53-62    اصل مقاله (392.77 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2020.87284.1742
نویسندگان
Reza Ebrahimoghli* 1؛ Ali Janati1؛ Homayoun Sadeghi-Bazargani2؛ Hadi Hamishehkar3؛ Atefeh Khalili-Azimi1
1Department of Health Policy and Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
2Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
چکیده
Background: Cardiovascular disease (CVD) is the most prevalent comorbid condition among patients with diabetes. The objective of this study is to determine the incremental healthcare resource utilization and expenditures (HRUE) associated with CVD comorbidity in diabetic patients.
Methods: In a cross-sectional study, patients receiving antidiabetic drugs were identified using the 2014 database of the Iran Health Insurance Organization of East Azerbaijan province (Iran). The frequency of HRUE was the main outcome. Outcome measures were compared between diabetic patients with and without CVD comorbidity during 2014-2016. The generalized regression model was used to adjust for cofounders because of a highly skewed distribution of data. Negative binomial regression and gamma distribution model were applied for the count and expenditure data, respectively.
Results: A total of 34,716 diabetic patients were identified, of which 21,659 (63%) had CVD comorbidity. The incremental healthcare resource utilization associated with CVD compared to non-CVD diabetic patients for physician services, prescription drugs, laboratory tests, and medical imaging was 5.9±0.34 (28% increase), 46±1.9 (46%), 12.9±0.66 (27%), and 0.16±0.40 (7%), respectively (all p <0.001). Similarly, extra health care costs associated with CVD comorbidity for physician services, prescription drugs, laboratory tests, and medical imaging were 10.6±0.67 million IRR (294.4±18.6 USD) (50% increase), 1.44±0.06 million IRR (40±1.6 USD) (32%), 8.36±0.57 million IRR (232.2±15.8 USD) (58%), 0.51±0.02 million IRR (14.1±0.5 USD) (24%), and 0.29±0.02 million IRR (8±0.5 USD) (22%), respectively (all p <0.001).
Conclusion: CVD comorbidity substantially increases HRUE in patients with diabetes. Our findings draw the attention of healthcare decision-makers to proactively prevent CVD comorbidity in diabetic patients.
کلیدواژه‌ها
Diabetes mellitus؛ Cardiovascular diseases؛ Comorbidity؛ Healthcare resources
سایر فایل های مرتبط با مقاله
مراجع
  1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137-49. doi: 10.1016/j.diabres.2013.11.002. PubMed PMID: 24630390.
  2. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract. 2014;103:319-27. doi: 10.1016/j.diabres.2013.12.034. PubMed PMID: 24447808.
  3. Collaboration NCDRF. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513-30. doi: 10.1016/S0140-6736(16)00618-8. PubMed PMID: 27061677; PubMed Central PMCID: PMCPMC5081106.
  4. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis. PLoS One. 2015;10:e0132505. doi: 10.1371/journal.pone.0132505. PubMed PMID: 26200913; PubMed Central PMCID: PMCPMC4511591.
  5. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018;17:83. doi: 10.1186/s12933-018-0728-6. PubMed PMID: 29884191; PubMed Central PMCID: PMCPMC5994068.
  6. Afarideh M, Noshad S, Ghajar A, Aryan Z, Khajeh E, Hosseini Shirvani S, et al. Family history of diabetes and the risk of coronary heart disease in people with or without type 2 diabetes. Diabetes Metab. 2017;43:180-3. doi: 10.1016/j.diabet.2016.07.032. PubMed PMID: 27644597.
  7. Fu AZ, Qiu Y, Radican L, Wells BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care. 2009;32:2187-92. doi: 10.2337/dc09-1128. PubMed PMID: 19729528; PubMed Central PMCID: PMCPMC2782975.
  8. Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15:487-97. doi: 10.1586/14737167.2015.1024661. PubMed PMID: 25824591.
  9. Mody R, Kalsekar I, Kavookjian J, Iyer S, Rajagopalan R, Pawar V. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. J Diabetes Complications. 2007;21:75-83. doi: 10.1016/j.jdiacomp.2006.02.005. PubMed PMID: 17331855.
  10. Colin X, Lafuma A, Gueron B. Costs of cardiovascular events of diabetic patients in the French hospitals. Diabetes Metab. 2007;33:310-3. doi: 10.1016/j.diabet.2006.12.004. PubMed PMID: 17395514.
  11. Ahmadi B, Alimohammadian M, Yaseri M, Majidi A, Boreiri M, Islami F, et al. Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis. Medicine (Baltimore). 2016;95:e2756. doi: 10.1097/MD.0000000000002756. PubMed PMID: 26886618; PubMed Central PMCID: PMCPMC4998618.
  12. Statistical Center of Iran [Internet]. Statistics by Topic, 2018, Presidency of The IRI Management and Planning Organization: Tehran. [cited 22 January 2019]. Available from: http:/ www.amar.org.ir
  13. Gorji HA, Mousavi S, Shojaei A, Keshavarzi A, Zare H. The challenges of strategic purchasing of healthcare services in Iran Health Insurance Organization: a qualitative study. Electron Physician. 2018;10:6299-306. doi: 10.19082/6299. PubMed PMID: 29629051; PubMed Central PMCID: PMCPMC5878022.
  14. Dong YH, Chang CH, Shau WY, Kuo RN, Lai MS, Chan KA. Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care database. Pharmacotherapy. 2013;33:126-36. doi: 10.1002/phar.1176. PubMed PMID: 23386595.
  15. Ebrahimoghli R, Janati A, Sadeghi-Bazargani H, Hamishehkar H, Ghaffari S, Sanaat Z, et al. Epidemiology of multimorbidity in Iran: An investigation of a large pharmacy claims database. Pharmacoepidemiol Drug Saf. 2020;29:39-47. doi: 10.1002/pds.4925. PubMed PMID: 31730260.
  16. Norbert H, Wanjoya A, Waititu A. Modeling and forecasting consumer price index (Case of Rwanda). American Journal of Theoritical and Applied Statistics. 2016;5:101-7. doi: 10.11648/j.ajtas.20160503.14.
  17. Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007;13:381-9. doi: 10.1111/j.1365-2753.2006.00711.x. PubMed PMID: 17518803.
  18. Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Health Care. 2011;23:331-41. doi: 10.1093/intqhc/mzr010. PubMed PMID: 21504959.
  19. Mihaylova B, Briggs A, O’Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20:897-916. doi: 10.1002/hec.1653. PubMed PMID: 20799344; PubMed Central PMCID: PMCPMC3470917.
  20. Belotti F, Deb P, Manning WG, Norton EC. twopm: Two-part models. The Stata Journal. 2015;15:3-20. doi: 10.1177/1536867X1501500102.
  21. Jann B. Making regression tables from stored estimates. The Stata Journal. 2005;5:288-308. doi: 10.1177/1536867X0500500302.
  22. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: OUP Oxford; 2014. doi: 10.1093/med/9780199685028.001.0001.
  23. Tong B, Stevenson C. Comorbidity of cardiovascular disease, diabetes and chronic kidney disease in Australia. Canberra: Australian Institute of Health and Welfare; 2007.
  24. Luijks H, Schermer T, Bor H, van Weel C, Lagro-Janssen T, Biermans M, et al. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med. 2012;10:128. doi: 10.1186/1741-7015-10-128. PubMed PMID: 23106808; PubMed Central PMCID: PMCPMC3523042.
  25. Alwakeel JS, Sulimani R, Al-Asaad H, Al-Harbi A, Tarif N, Al-Suwaida A, et al. Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia. Ann Saudi Med. 2008;28:260-6. doi: 10.5144/0256-4947.2008.260. PubMed PMID: 18596402; PubMed Central PMCID: PMCPMC6074352.
  26. Jurado J, Ybarra J, Solanas P, Caula J, Gich I, Pou JM, et al. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study. J Am Acad Nurse Pract. 2009;21:140-8. doi: 10.1111/j.1745-7599.2008.00377.x. PubMed PMID: 19302689.
  27. Song SH, Hardisty CA. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort. QJM. 2009;102:799-806. doi: 10.1093/qjmed/hcp121. PubMed PMID: 19734298.
  28. Mehta S, Ghosh S, Sander S, Kuti E, Mountford WK. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease. J Manag Care Spec Pharm. 2018;24:280-90. doi: 10.18553/jmcp.2018.24.3.280. PubMed PMID: 29485954.
  29. Erwin G, Iyer S, Rajagopalan R, Astuto J, Wilson P, Schaneman J, et al. Type 2 diabetes mellitus treatment patterns and healthcare costs in the elderly population. Disease Management & Health Outcomes. 2006;14:75-83. doi: 10.2165/00115677-200614020-00002.
  30. Li R, Bilik D, Brown MB, Zhang P, Ettner SL, Ackermann RT, et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care. 2013;19:421-30. PubMed PMID: 23781894; PubMed Central PMCID: PMCPMC4337403.
  31. Boult C, Wieland GD. Comprehensive primary care for older patients with multiple chronic conditions: “Nobody rushes you through”. JAMA. 2010;304:1936-43. doi: 10.1001/jama.2010.1623. PubMed PMID: 21045100.
  32. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269-76. doi: 10.1001/archinte.162.20.2269. PubMed PMID: 12418941.
  33. Force M, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035-87. doi: 10.1093/eurheartj/eht108. PubMed PMID: 23996285.
  34. Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28:516-23. doi: 10.1093/fampra/cmr013. PubMed PMID: 21436204.
  35. Teljeur C, Smith SM, Paul G, Kelly A, O’Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract. 2013;19:17-22. doi: 10.3109/13814788.2012.714768. PubMed PMID: 23432037.
  36. Maio V, Yuen E, Rabinowitz C, Louis D, Jimbo M, Donatini A, et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy. 2005;10:232-8. doi: 10.1258/135581905774414259. PubMed PMID: 16259690.
  37. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197-203. doi: 10.1016/0895-4356(92)90016-g. PubMed PMID: 1573438.
آمار
تعداد مشاهده مقاله: 4,033
تعداد دریافت فایل اصل مقاله: 1,899


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب